This treatment combination together achieved the suppression of phosphorylated Akt, NF‐kB, COX‐2, and prostaglandin levels, where the researchers described it as a new therapeutic option for breast cancer because of the antiproliferation was dependent on the dose given.155. The gene discussed is AKT1; the disease is breast carcinoma.